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Each year, approximately 65 000 hip fractures occur in the United Kingdom, 1 with a cost of between two and three billion pounds to the NHS. 2 Globally, 1.6 million hip fractures occur each year, which could rise to six million by 2050. 3 For hip fractures, treatment aims are to relieve pain and restore function with the lowest possible morbidity and mortality. Trochanteric fractures represent between one third and one half of these fractures, and whether they should be treated using an extramedullary device such as a sliding hip screw (SHS) or an intramedullary nail (IMN) remains controversial. 1, [4] [5] [6] [7] [8] Some authors recommend the use of a SHS in all patients; 6 others recommend the use of an IMN in all but the most simple fractures, 7 and a third group suggest that either device can be used. 8 An IMN can be short or long. Long nails are preferred for the treatment of certain types of fracture such as pathological and atypical fractures, in order to provide fixation throughout the whole femur. IMNs have recently been used more commonly for the treatment of trochanteric fractures in the United States. 9 This is despite their greater expense compared with SHSs. 6 There has also been a trend towards decreased use of SHS for trochanteric fractures in the NHFD; 84% in 2011 and 80% in 2016. The NHFD records substantial variation between hospitals with 4% of patients with a trochanteric hip fracture being treated with a SHS in some compared with 100% in others. 10 A recent Cochrane review concluded that SHSs have fewer complications and equivalent functional outcomes when compared with IMNs. 11 While this review found no difference in mortality between the two procedures, the studies to date have been underpowered to detect such a difference.
The aim of this study was to compare the rates of mortality in the first 30 days following the  TRAUMA Higher 30-day mortality associated with the use of intramedullary nails compared with sliding hip screws for the treatment of trochanteric hip fractures
Results
The use of short and long intramedullary nails was associated with an increase in 30-day mortality (adjusted odds ratio (OR) 1.125, 95% confidence interval (CI) 1.040 to 1.218; p = 0.004) compared with the use of sliding hip screws (12.5% increase). If this were causative, it would represent 98 excess deaths over the four-year period of the study and one excess death would be caused by treating 112 patients with an intramedullary nail rather than a sliding hip screw.
Conclusion
There is a 12.5% increase in the risk of 30-day mortality associated with the use of an intramedullary nail compared with a sliding hip screw in the treatment of a trochanteric fractures of the hip. surgical management of a trochanteric fracture with a SHS or an IMN using information from the UK National Hip Fracture Database (NHFD). The hypothesis was that mortality may be higher with an IMN due to instrumentation of the intramedullary femoral canal.
Patients and Methods
Using data from the NHFD, we investigated the 30-day rates of mortality following the surgical treatment of a trochanteric fracture with either a SHS or a long or short IMN. All patients treated in this way in England and Wales between 2011 and 2014 were included. The NHFD began collecting these data in 2007, and since January 2011 it has captured more than 95% of these patients. 12 Crown Informatics, which is the processor of NHFD data, passed details of patients with traceable NHS numbers to the NHS Personal Demographics Service, who linked the database to mortality data from the Office for National Statistics (ONS). Anonymized data were then passed to the research team.
All patients admitted with a trochanteric fracture between 1 January 2011 and 31 December 2014 and who underwent surgery within 30 days of admission, or the date of the fracture if they were already an inpatient, were included. Exclusion criteria included those aged less than 60 years or more than 120 years, those with an intracapsular or subtrochanteric fracture, those whose surgery involved operations other than SHS or IMN, or if the time to surgery was less than 0 hours or more than 30 days. Patients with missing data relating to age, gender, residence, destination of discharge, length of stay (or where the length of stay was recorded as less than 0 hours), or mortality status at 30 days were excluded (Fig. 1) .
The primary outcome was death at 30 days following fracture. Deaths occurring prior to 30 days were determined using a combination of Office for National Statistics death records and/ or time of discharge, or discharge destination, which also indicates when a patient has died. Contralateral hip fractures in the same patient were considered independent events. The primary exposure was the type of operation that was undertaken: SHS, or long or short IMN.
All analyses were adjusted for the month and year of admission 4, 13 due to the strong association between mortality and season. 4 Models also included patient-level factors (Sunday surgery, 4 time to surgery, out-of-hours surgery, age, gender, pre-admission residence, American Society of Anesthesiologists (ASA) grade, 14 preoperative abbreviated mental test score (AMTS), 15 pathological fracture, preoperative mobility), non-surgical factors (falls assessment, multidisciplinary team (MDT) assessment), perioperative factors (type of anaesthetic), and socioeconomic confounding factors (Supplementary Table i ). Statistical analysis. Means, standard deviations, and interquartile ranges (IQRs) were used to describe continuous variables. Frequencies and percentages were used to describe categorical variables. The associations between 30-day mortality and surgery were modelled using logistic regression. Adjustment for confounding variables was conducted incrementally (Table I) . Model 0 was not adjusted. Model 1 was adjusted for patientlevel confounding variables. Model 2 was further adjusted for non-surgical factors. Model 3 was further adjusted for perioperative factors. Model 4 was further adjusted for socioeconomic factors. Given the strength of the seasonal association with mortality, we used a variety of seasonal model specifications to investigate the sensitivity of the primary effect to these assumptions using two alternative specifications, an elapsed month parameterization and a trigonometric regression (Fourier series). 16, 17 Data were examined for interactions between the primary exposure and ASA grade and gender. All analyses were conducted in Stata 14.0 (StataCorp LP, College Station, Texas).
In patients with missing data, assuming the data were missing at random, we imputed missing values using multiple imputation with chained equations (MICE; Supplementary Table ii) . Gender-specific imputation models were used for each variable that contained missing data and were combined before analysis. A total of 100 gender-specific imputed data sets were generated with a burn-in of 30 repetitions. This allowed analysis of 82 990 cases in the models specified above. Complete case and multiple imputation case data are presented for clarity.
Results
A total of 258 891 treatment episodes for a hip fracture were undertaken during the study period. Following the application of the inclusion and exclusion criteria, 82 990 were available for analysis, of which 30 509 (36.8%) had one or more missing data completed using MICE (Fig. 1) .
A total of 26% of the trochanteric fractures were in men, in whom the crude 30-day mortality rate was higher than in women (10.6% vs 6.7%). A SHS was used in 86.7% of fractures, a long IMN in 7.9%, and a short IMN in 5.5%. The age of the patients, preoperative AMTS, and length of time to surgery were similar in the three groups (Table II) , as were the type of residence from which patients were admitted, ASA grade, preoperative mobility, whether MDT and falls assessment were conducted, and type of anaesthesia (Table III) . As expected, there was a higher proportion of patients with a pathological fracture in the long IMN group (4.1%; n = 187) compared with the SHS (0.6%; n = 255) and short IMN groups (1.0%; n = 29). In those alive at 30 days, the crude length of stay was longest for the long IMN group (median 18.2 days, IQR 11.4 to 32.1) compared with the short IMN (median 16.8 days, IQR 10.7 to 28.3) and the SHS group (median 16.5 days, IQR 10.1 to 29.1), although these differences were small with wide variance.
In the unadjusted analysis, the 30-day mortality was lowest for the SHS group (7.6%), then the short IMN (8.2%) and the long IMN (8.3%) groups. These differences persisted in logistic regression models, despite adjustment for patient, non-surgical, perioperative, and socioeconomic factors (Table IV) . The IMN groups were combined for further analysis. In crude analysis of complete case data, the use of an IMN was associated with higher odds of death at 30-days (odds ratio (OR) 1.148, 95% confidence interval (CI) 1.046 to 1.261; p = 0.004) compared with the use of a SHS. This association, although weaker, persisted after multiple imputation (OR 1.092, 95% CI 1.015 to 1.175; p = 0.018) ( Table V) . Following multiple imputation and adjustment for patient, non-surgical, perioperative, and socioeconomic confounding factors, there was also an association between the use of an IMN and higher 30-day mortality (OR 1.125, 95% CI 1.040 to 1.218; p = 0.004) compared with the use of a SHS. The crude mortality of those treated with SHS was The inclusion and exclusion criteria of the study. 7.63%, and assuming the OR increase in mortality due to the use of IMNs was 1.125 and the choice of operation is causative, this would correspond to an excess of 98 deaths during the four years of the study period. Alternatively, the number of patients treated with an IMN rather than a SHS to cause one excess death would be 112 assuming that the choice of operation was causative. Sensitivity analyses using elapsed month parameterization and trigonometric regression did not alter the interpretation a substantially larger number of patients than was included in 30 previous randomized controlled trials (RCTs) which were not adequately powered to detect a difference in mortality outcomes.
It was reassuring to note that 87% of trochanteric fractures in this cohort were treated with a SHS. However, between 2011 and 2016 this number has decreased to 75% nationally and there is significant unexplained national and global variation.
1,18
Guidelines from the American Association of Orthopedic Surgeons support the use of an IMN over a SHS to treat unstable trochanteric fractures (AO classification: 31A2 and 31A3), and give equal recommendation to both treatments for stable fractures (31A1). 19 A survey of 3784 orthopaedic surgeons in the USA revealed that only 19% primarily use a SHS for the treatment of trochanteric hip fractures, 18 despite the proven cost effectiveness of the SHS. 20 The decline in use of sliding hip screws has been well documented. [21] [22] [23] This is usually justified by the theoretical biomechanical advantages associated with IMNs, despite the lack of robust evidence to support this. 11 It is difficult to determine the influence of industry and reimbursement practices 21 on such a precipitous change in practice. Current guidance from the National Institute for Health and Care Excellence (NICE) in the United Kingdom states that a SHS should be used in preference to an IMN for trochanteric (AO classification 31A1 and 31A2) fractures. 24 A 2017 meta-analysis compared mortality after the use of SHSs and IMNs specifically to treat more unstable 31A2 fractures, where any theoretical benefit of improved stability should be most marked between the types of fixation. 25 Four RCTs that were included reported pooled crude rates of one-year mortality of 13% following the use of 297 SHSs, and 17% following the use 303 IMNs (relative risk 1.33, 95% CI 0.92 to 1.93; p = 0.13). [26] [27] [28] [29] One-year mortality may not, however, represent a sensitive measure of the effect of the operation in the frail, elderly patients who sustain a hip fracture. A study of the medical records of 709 consecutive patients admitted with a hip fracture showed that, of 258 patients who had died within one year of the operation, 33% of deaths were unrelated and only 25% were directly related to the fracture. 30 Mortality rates are seen to fall dramatically after an initial postoperative spike. 31 30-day mortality has been shown to provide a more discriminatory measure of operations in other studies of orthopaedic surgery in elderly patients. 32, 33 Only one trial included in the 2017 meta-analysis reported 30-day mortality. In this trial, 21% of 100 patients treated with an IMN had died at 30 days, compared with 10% of 110 patients treated with a SHS (hazard ratio 1.69, 95% CI 0.91 to 3.45; p = 0.13). 29 The data in this study do not allow us to determine the cause of this difference. The most obvious difference between the operations is the instrumentation of the femoral canal. We feel that the deleterious effects associated with this are the most likely cause of the difference in mortality. Intramedullary nailing is known to be associated with increased intramedullary pressure, embolic showers, and fat intravasation, 34 features that elderly patients do not cope well with due to poor physiological reserve. As increased pressures are observed, even during simple manoeuvres such as introducing a guide wire, 35 it would be expected that the observed effect is the same whether long or short nails are used, as is the case in this study. The introduction of an IMN in these elderly patients may represent a 'second hit' during a physiologically vulnerable period. 36 The NHFD is a disease-specific national prospective audit, which captured more than 95% of patients during the period of the study. 12 This rate of capture has continued to improve with the 2017 NHFD report indicating that all 177 eligible hospitals contributed data. In comparison to the Hospital Episodes Statistics database, which is generally considered the benchmark for case ascertainment in the NHS, ascertainment rates were 104% indicating under-reporting in HES. The data set contains detailed information on patient, non-surgical, perioperative, and socioeconomic confounding factors that allow for relevant risk adjustment when outcomes such as 30-day mortality are considered. The number of mandatory fields for data collection, together with a Best Practice Tariff 37 that encourages data capture, ensures a high rate of capture. Despite the number of patients involved, inferring causal effects from prospective observational data remains problematic and, in this analysis, we were only able to determine an association, not causation.
Although it is reassuring that the results of our adjusted analyses, with multiple imputation for missing variables, were consistent with the crude analysis and incremental adjustments, we are aware of the limitations associated with the interpretation of the data. The NHFD does not capture data about the reasons for selecting the type of operation which is performed; whether an IMN, for instance, is selected for patients at a high risk of death is not known (i.e. unknown confounding by indication). However, the variation in the pattern of use in different hospitals suggests hospital-level rather than patient-level characteristics may play a greater role. We did not have data on comorbidities to test this assumption. It is possible that adjustment for comorbidities, not available in the NHFD beyond that provided by ASA grade, may have produced different results. However, this is unlikely given that the scores used to predict mortality in patients with a hip fracture do not show greater discrimination when comorbidities are included in the analysis rather than ASA. 38 We observed, as expected, that a higher proportion of patients with a pathological fracture were treated with a long IMN and our model accounted for this variation. Classification of hip fractures in the NHFD is carried out by the treating team and it is possible that some fractures were misclassified. Another limitation is that all patterns of trochanteric fractures (AO/Orthopaedic Trauma Association (OTA) A1, A2, and A3 fractures) are grouped together in the data set. The current evidence about the treatment of A3 fractures, which represent a small subset (8% of trochanteric fractures), is inconclusive, and NICE recommends that either a SHS or IMN can be used. Currently there is no conclusive evidence to show that more severe patterns of fracture independently predict mortality in these patients. Accordingly, scores that predict the risk of mortality after a hip fracture do not include the type of fracture beyond the broad categorization that we used. 38, 39 We studied 30-day mortality as a binary indicator; we did not have data on the cause of death, which meant that we could not determine which deaths may have been associated with, or attributable to, the type of operation. Other outcomes, such as length of stay, rates of postoperative mobilization, and perioperative complications will be relevant to healthcare providers and patients but were beyond the scope of the analysis. The costs of implants alone are three times higher for short IMNs than SHSs, and more than 4.5 times higher for long IMNs than SHSs. 6 We do not have sufficient data to provide robust health economic estimates of differences between the types of operation.
We analyzed data from a large and generalizable national database and have demonstrated a statistically significantly elevated risk of death at 30 days in patients with a trochanteric fracture who are treated with both short and long IMNs, compared with those treated with SHSs. Therefore, the growing global trend towards increased use of intramedullary nails for the treatment of this common fracture type is not currently justified.
A RCT adequately powered for mortality would be difficult to deliver. In order to be adequately powered, with an alpha value of 0.05, a power of 0.8 and an effect size of 0.1 on 30-day mortality, a simply designed RCT with a 1:1 allocation ratio would require a sample size of 23 645 patients per group. Alternative designs, such as cluster randomized trials, may be appropriate for the study of these operations in patients with a hip fracture, with efficient data collection through routinely collected data sources such as the NHFD. Cluster designs would, however, have the effect of increasing the sample size when they account for variation between centres (or clusters).
Patients, surgeons, and other stakeholders need to be aware of the increased risk of 30-day mortality associated with the use of IMNs compared with SHSs when selecting and commissioning operations. Given the current lack of robust evidence to support the use of IMNs over SHSs for the treatment of trochanteric fractures and the higher cost of IMNs, we recommend that a SHS should be the preferred operation for these patients.
Take home message
-Due to the association with lower mortality, sliding hip screws should be used in preference to intramedullary nails to treat trochanteric fractures of the hip, other than for particular subtypes of fracture such as pathological and atypical fractures. -Further randomized controlled trials comparing intra-and extramedullary devices should not be performed unless they are adequately powered to detect a difference in mortality between treatment groups.
Supplementary material
Tables showing: deciles of income deprivation; multiple imputation via chained equations model (MICE) model specification; sensitivity analyses for exposure groups defined by the implants used; and crude 30-day mortality rates (%) by American Society of Anesthesiologists (ASA) grade for subsets of trochanteric fractures with complete case data.
